August 6, 2014

Clearing the Air - Asthma and Indoor Air Exposures


.
Washington (DC): National Academies Press (US).
ISBN-10: 0-309-06496-1
Since about 1980, asthma prevalence and asthma-related hospitalizations and deaths have increased substantially, especially among children. Of particular concern is the high mortality rate among African Americans with asthma.
Recent studies have suggested that indoor exposures--to dust mites, cockroaches, mold, pet dander, tobacco smoke, and other biological and chemical pollutants--may influence the disease course of asthma. To ensure an appropriate response, public health and education officials have sought a science-based assessment of asthma and its relationship to indoor air exposures.
Clearing the Air meets this need. This book examines how indoor pollutants contribute to asthma-- its causation, prevalence, triggering, and severity. The committee discusses asthma among the general population and in sensitive subpopulations including children, low-income individuals, and urban residents. Based on the most current findings, the book also evaluates the scientific basis for mitigating the effects of indoor air pollutants implicated in asthma. The committee identifies priorities for public health policy, public education outreach, preventive intervention, and further research.

Contents

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.
Copyright 2000 by the National Academy of Sciences. All rights reserved.
Bookshelf ID: NBK224477PMID: 25077220

Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis




    A Roy
    , senior scientist1
  1. M Eisenhut, consultant paediatrician2
  2. R J Harris, statistician1
  3. L C Rodrigues, professor of epidemiology3
  4. S Sridhar, research associate4
  5. S Habermann, junior doctor2
  6. L Snell, junior doctor2
  7. P Mangtani, senior lecturer3
  8. I Adetifa, paediatrician and medical epidemiologist5
  9. A Lalvani, professor of infectious disease4
  10. I Abubakar, professor of infectious disease epidemiology16
    Author affiliations
  1. Correspondence to: I Abubakar i.abubakar@ucl.ac.uk
  • Accepted 11 July 2014

Abstract

Objectives To determine whether BCG vaccination protects against Mycobacterium tuberculosis infection as assessed by interferon γ release assays (IGRA) in children.
Design Systematic review and meta-analysis. Searches of electronic databases 1950 to November 2013, checking of reference lists, hand searching of journals, and contact with experts.
Setting Community congregate settings and households.
Inclusion criteria Vaccinated and unvaccinated children aged under 16 with known recent exposure to patients with pulmonary tuberculosis. Children were screened for infection with M tuberculosis with interferon γ release assays.
Data extraction Study results relating to diagnostic accuracy were extracted and risk estimates were combined with random effects meta-analysis.
Results The primary analysis included 14 studies and 3855 participants. The estimated overall risk ratio was 0.81 (95% confidence interval 0.71 to 0.92), indicating a protective efficacy of 19% against infection among vaccinated children after exposure compared with unvaccinated children. The observed protection was similar when estimated with the two types of interferon γ release assays (ELISpot or QuantiFERON). Restriction of the analysis to the six studies (n=1745) with information on progression to active tuberculosis at the time of screening showed protection against infection of 27% (risk ratio 0.73, 0.61 to 0.87) compared with 71% (0.29, 0.15 to 0.58) against active tuberculosis. Among those infected, protection against progression to disease was 58% (0.42, 0.23 to 0.77).
Conclusions BCG protects against M tuberculosis infection as well as progression from infection to disease.
Trial registration PROSPERO registration No CRD42011001698 (www.crd.york.ac.uk/prospero/).

August 4, 2014

The quality of reporting of randomised controlled trials in asthma: a systematic review.


 2013 Dec;22(4):417-24. doi: 10.4104/pcrj.2013.00089.

Abstract

BACKGROUND:

There are concerns about the reporting quality of asthma trials.

AIMS:

To describe the reporting of contemporary asthma trials and to identify factors associated with better reporting quality.

METHODS:

Two reviewers independently searched MEDLINE for randomised controlled trials (RCTs) of asthma published between January 2010 and July 2012 in leading generalist and specialist journals. We calculated the proportion of trials that adequately reported each Consolidated Standards of Reporting Trials (CONSORT) checklist item and an overall quality score for each trial. Factors associated with better reporting quality were investigated.

RESULTS:

Thirty-five RCTs satisfied our eligibility criteria. Four trials adequately reported -50% of the items, 15 adequately reported 50-60% of items, and 16 adequately reported >60% of items. Seventeen of the 38 CONSORT items were consistently well reported in more than two-thirds of the articles. In contrast, nine items were poorly reported in more than half the trials - namely, identification as a randomised trial in the title (40.0%), an adequate structured summary/abstract (48.6%), details of eligibility criteria (34.3%), recruitment (48.6%), randomisation procedures (22.9%), intervention (38.5%), harms (34.3%), the funding source (45.7%), and access to the full trial protocol (17.1%). Studies led by teams in high-income country settings were associated with better quality of reporting (relative risk=1.33, 95% CI 1.09 to 1.64).

CONCLUSIONS:

The quality of reporting in contemporary asthma literature remains suboptimal. We have identified important areas in which reporting quality needs to be improved.
PMID:
 
24248328
 
[PubMed - indexed for MEDLINE] 
Free full text